phase readout
saveNCT03756298: Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
ACTIVE_NOT_RECRUITINGupdated 22h ago
community read0 votes
Sponsor: National Cancer Center, Korea. Phase: PHASE2. Conditions: Triple Negative Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that